HEE-JUNG SONG

Prof. Dr. HEE-JUNG SONG

Chungnam National University, Republic of Korea
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in JACC
Verified
Journal Article
Closed access
PLPil Hyung Lee
Pil Hyung Lee
JSJae-Kwan Song
Jae-Kwan Song
JKJong S. Kim
Jong S. Kim
RHRan Heo
Ran Heo
SLSahmin Lee
Sahmin Lee
SPSeung-Jung Park
Seung-Jung Park

1 January 2014 in Stroke
Verified
Journal Article
Closed access
JHJi Man Hong
Ji Man Hong
JLJin Soo Lee
Jin Soo Lee
HSHEE-JUNG SONG
HEE-JUNG SONG
HJHye Seon Jeong
Hye Seon Jeong
HCHuimahn Alex Choi
Huimahn Alex Choi
KLKiwon Lee
Kiwon Lee
Background and Purpose—: Therapeutic hypothermia improves outcomes in experimental stroke models, especially after ischemia-reperfusion injury. We investigated the clinical and radiological effects of therapeutic hypothermia in acute ischemic stroke patients after recanalization. Methods—: A prospective cohort study at 2 stroke centers was performed. We enrolled patients with acute ischemic stroke in the anterior circulation with an initial National Institutes of Health Stroke Scale ≥10 who had successful recanalization (≥thrombolysis in cerebral ischemia, 2b). Patients at center A underwent a mild hypothermia (34.5°C) protocol, which included mechanical ventilation, and 48-hour hypothermia and 48-hour rewarming. Patients at center B were treated according to the guidelines without hypothermia. Cerebral edema, hemorrhagic transformation, good outcome (3-month modified Rankin Scale, ≤2), mortality, and safety profiles were compared. Potential variables at baseline and during the therapy were analyzed to evaluate for independent predictors of good outcome. Results—: The hypothermia group (n=39) had less cerebral edema ( P =0.001), hemorrhagic transformation ( P =0.016), and better outcome ( P =0.017) compared with the normothermia group (n=36). Mortality, hemicraniectomy rate, and medical complications were not statistically different. After adjustment for potential confounders, therapeutic hypothermia (odds ratio, 3.0; 95% confidence interval, 1.0–8.9; P =0.047) and distal occlusion (odds ratio, 7.3; 95% confidence interval; 1.3–40.3; P =0.022) were the independent predictors for good outcome. Absence of cerebral edema (odds ratio, 5.4; 95% confidence interval, 1.6–18.2; P =0.006) and no medical complications (odds ratio, 9.3; 95% confidence interval, 2.2–39.9; P =0.003) were also independent predictors for good outcome during the therapy. Conclusions—: In patients with ischemic stroke, after successful recanalization, therapeutic hypothermia may reduce risk of cerebral edema and hemorrhagic transformation, and lead to improved clinical outcomes.

2 November 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HSHyo Jung Shin
Hyo Jung Shin
HPHyewon Park
Hyewon Park
NSNARA SHIN
NARA SHIN
HKHyeok Hee Kwon
Hyeok Hee Kwon
YYYuhua Yin
Yuhua Yin
JBJaewon Beom
Jaewon Beom
Cartilage loss is a central event in the pathogenesis of osteoarthritis (OA), though other than mechanical loading, the biochemical mechanisms underlying OA pathology remain poorly elucidated. We investigated the role of Pink1-mediated mitophagy in mitochondrial fission, a crucial process in OA pathogenesis. We used a monosodium iodoacetate (MIA)-induced rodent model of OA, which inhibits the activity of articular chondrocytes, leading to disruption of glycolytic energy metabolism and eventual cell death. The OA rat cartilage exhibits significant induction of autophagy-related proteins LC3B and p62, similar to human osteoarthritic cartilage. Moreover, expression of Pink1 and Parkin proteins were also increased in OA. Here, we confirm that Pink1-mediated mitophagy leads to cell death in chondrocytes following MIA treatment, while deficiency in Pink1 expression was associated with decreased cartilage damage and pain behaviors in MIA-induced OA. Finally, we found that autophagy and mitophagy-related genes are highly expressed in human osteoarthritic cartilage. These results indicate that OA is a degenerative condition associated with mitophagy, and suggest that targeting the Pink1 pathway may provide a therapeutic avenue for OA treatment.

1 July 2012 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
HKHyun Jung Kim
Hyun Jung Kim
EOEung Seok Oh
Eung Seok Oh
JLJi Hee Lee
Ji Hee Lee
JMJung Soo Moon
Jung Soo Moon
JOJi Eun Oh
Ji Eun Oh
ALAe Young Lee
Ae Young Lee

1 May 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JPJung-Bum Park
Jung-Bum Park
HNHarsha Nagar
Harsha Nagar
SCSujeong Choi
Sujeong Choi
SJSaet-Byel Jung
Saet-Byel Jung
HKHyun-Woo Kim
Hyun-Woo Kim
Cuk-Seong KimCuk-Seong Kim
Cuk-Seong Kim

1 September 2018 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
JPJong-Moo Park
Jong-Moo Park
BKBum Joon Kim
Bum Joon Kim
SKSun U. Kwon
Sun U. Kwon
YHYang-Ha Hwang
Yang-Ha Hwang
SHSung Hyuk Heo
Sung Hyuk Heo
JLJuneyoung Lee
Juneyoung Lee
Current guideline recommends intensive blood pressure (BP) control in hypertensive patients, but the appropriate target BP level after ischemic stroke due to intracranial atherosclerotic stenosis remains uncertain. In this randomized, single-blinded trial, patients with symptomatic internal carotid or middle cerebral artery steno-occlusion (>50%) within 7–42 days after index stroke received intensive (target SBP < 120 mmHg) or modest (target SBP < 140 mmHg) BP control from April 2010 to December 2012. The primary outcome was the change in ischemic lesion volume in white matter lesions at the whole forebrain between baseline and 24 weeks as measured from fluid attenuation inversion recovery (FLAIR) images, which was tested in noninferiority test (noninferiority margin of 3 cm3). Among 132 patients, follow-up FLAIR images were available in 111 (59 in the intensive and 52 in the moderate BP control groups). After 24 weeks, the SBP in the intensive group was significantly lower (124.6 ± 10.5 mmHg) than in the modest group (132.3 ± 10.6 mmHg). The ischemic lesion volume increased more in the intensive group (4.9 ± 18.3 cm3) than the modest group (2.2 ± 8.2 cm3), which failed to prove noninferiority. The frequency of new ischemic lesions on 24-week FLAIR images was nonsignificantly higher in the intensive group than the modest group [10 (16.9%) vs. 5 (9.6%), respectively; P = 0.26)]. Only one recurrent stroke developed during the study period in each group. Intensive BP control in intracranial atherosclerotic stenosis patients failed to prove noninferiority compared with modest BP control, and may increase ischemic lesion volume in the subacute stage.